Literature DB >> 9604823

Serum phenytoin levels of patients on gastrostomy tube feeding.

B Faraji1, P P Yu.   

Abstract

Serum phenytoin levels of two groups of brain-injured patients on gastrostomy tube (GT) feeding were retrospectively examined. In the first group (group C = clamped, n = 13), GT was clamped for one hour after the phenytoin dose (2-3 doses per day), and in the second group (group NC = not clamped, n = 9) GT feedings were continued without interruption. Mean +/- SD of the serum phenytoin levels was 14.4 +/- 4.7 micrograms/ml for group C, and 9.2 +/- 6.8 micrograms/ml for group NC. When serum phenytoin levels were adjusted for decreased serum albumin levels, the results were 19.8 +/- 6.4 micrograms/ml for group C and 11.7 +/- 7.9 micrograms/ml for group NC. Statistical analysis showed a significant difference between the means in both the phenytoin and adjusted phenytoin levels between the two groups (p < 0.05). No significant difference was found in phenytoin dosage per kg of body weight, protein intakes, calcium, magnesium and sodium per 24 hours between the means for the two groups. Results of this study suggest that clamping the GT for one hour after the phenytoin dose results in higher serum levels of the drug.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9604823     DOI: 10.1097/01376517-199802000-00001

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  3 in total

1.  A Text Mining Protocol for Extracting Drug-Drug Interaction and Adverse Drug Reactions Specific to Patient Population, Pharmacokinetics, Pharmacodynamics, and Disease.

Authors:  Mohamed Saleem Abdul Shukkoor; Mohamad Taufik Hidayat Baharuldin; Kalpana Raja
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Gastrostomy feeding in cerebral palsy: a systematic review.

Authors:  G Sleigh; P Brocklehurst
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

3.  Steady-state serum phenytoin concentrations after nasogastric tube administration of immediate-release phenytoin tablets and extended-release phenytoin capsules: an open-label, crossover, clinical trial.

Authors:  Duangchit Panomvana; Napanan Khummuenwai; Supasil Sra-Ium; Somchai Towanabut
Journal:  Curr Ther Res Clin Exp       Date:  2007-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.